Back
Praxis Precision Medicines, Inc. Vs. Nebius Group NV Industry Stock Comparison
Sell
48
PRAX
Praxis Precision Medicines, Inc.
Last Price:
$310.87
Seasonality Move:
-15.68%
Buy
51
NBIS
Nebius Group NV
Last Price:
$108.86
Seasonality Move:
16.36%
Sell
48
Praxis Precision Medicines, Inc. (PRAX)
is a Sell
Is Praxis Precision Medicines, Inc. a Buy, Sell or Hold?
-
The current Praxis Precision Medicines, Inc. [PRAX] share price is $310.38. The Score for PRAX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $108.82. The Score for NBIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRAX Stock Price Chart
What is Praxis Precision Medicines, Inc.'s stock price today?
-
The Praxis Precision Medicines, Inc. share price today is $310.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing selling pressure, which indicates risk of future bearish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $108.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.79 | Sell |
| Relative Strength Index (14 RSI): | 51.43 | Buy |
| Chaikin Money Flow: | -211560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (292.69 - 320.11) | Buy |
| Bollinger Bands (100): | (228.11 - 329.95) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | 13258215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.12 - 116.9) | Buy |
| Bollinger Bands (100): | (86.58 - 107.22) | Buy |
PRAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 303.46 | Buy |
| 20-day SMA: | 301.93 | Buy |
| 50-day SMA: | 313.63 | Sell |
| 200-day SMA: | 174.54 | Buy |
| 8-day EMA: | 305.78 | Buy |
| 20-day EMA: | 305.79 | Buy |
| 50-day EMA: | 301.69 | Buy |
| 200-day EMA: | 208.49 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.45 | Buy |
| 20-day SMA: | 108.76 | Buy |
| 50-day SMA: | 99.99 | Buy |
| 200-day SMA: | 89.14 | Buy |
| 8-day EMA: | 105.76 | Buy |
| 20-day EMA: | 106.36 | Buy |
| 50-day EMA: | 102.68 | Buy |
| 200-day EMA: | 86.85 | Buy |
Praxis Precision Medicines, Inc. Earnings Growth & PRAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.60 per share, a decrease next quarter of $0.08 per share, a decrease this year of $2.11 per share, and an increase next year of $6.57 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.82 per share, a decrease this year of $0.72 per share, and an increase next year of $1.68 per share.
Praxis Precision Medicines, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||